1Stock S,Leichner P, Wong AC, et al. Ghrelin, peptide YY, glucosedependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents [J]. J Clin Endocrinol Metab,2005,90(4) :2161 -2168.
2Ballantyne GH. Peptide YY ( 1-36 ) and peptide YY ( 3-36 ) Part I distribution, release and actions [J]. Obese Surg, 2006,16 ( 5 ) : 651 - 658.
3Pittner RA, Moore CX, Bhavsar SP,et al. Effects of PYY(3-36) in rodent models of diabetes and obesity[ J ]. Int J Obes Relat Metab Disord ,2004,28 ( 8 ) : 963 - 971.
4Yang N, Wang C, Xu M,et at. Interaction of dietary composition and PYY gene expression in diet - induced obesity in rats [ J ]. J Huazhong Univ Sci Technol Med Sci,2005,25 (3) : 243 - 246.
5Sainsbury A, Bergen HT, Boey D, et al. Y2 Y4 receptor double knock out pi'otects against obesity due to a high-fat diet or Y1 receptor deficiency in mice [J].Diabetes,2006,55 ( 1 ) : 19 - 26,
6Batterham RL, Cohen MA, Ellis SM,et al. Inhibition of food intake in obese subjects by peptide YY[J]. N Engl J Med ,2003 ,349 :941 - 948.
7Roth C, Enriori P, Harz K,et al. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss[J]. J Clin Endocrinol Metab ,2005,90 ( 12 ) :6386 - 6391.
8Renshaw D, Batterham RL. Peptide YY:A potential therapy for obesity[J]. Curr Drug Targets,2005,6(2) :171 - 179.
9Gantz I, Erondu N, Mallick M,et al. Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults [ J ]. J Clin Endocrinol Metab ,2007,92(5 ) : 1754 - 1757.
10Tschop M, Castaoeda TR, Joost HG, et al. Physiology : Does gut hormone PYY3 -36 decrease food intake in rodents? [ J]. Nature, 2004,430 ( 6996 ) : 1 - 3.
6American Diabetes Association. Hypertension management in a- dults with diabetes[ J]. Diabetes Care, 2004, 27 (Supple 1 ) : 65 - 67.
7Liu Y, Qiu CC ,Zhou WY, et al. Gene polymorphisms of the rennin -angiotensin system in essential hypertension [ J ]. Chin Med J, 1999,112(2) :115 - 120.
8McGettfick AJ, Feener EP, Kahn CR. Human insulin receptor substrate - 1 ( IRS - 1 ) polymorphism G972R causes IRS - 1 to associate with the insulin receptor and inhibit receptor autophos- phorylation[J]. J Biol Chem,2005,280(8) :6441 -6446.
9Perticone F, Sciacqua A, Scozzafava A, et al. Impaired endothelial function in never - treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate - 1 gene [ J ]. J Clin Endocrinol Metab,2004,89 ( 7 ) : 3606 - 3609.
10UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38[J]. BMJ,2008,317:703 -713.